What is the primary purpose of neuropsychological assessments in cognitive dysfunction?
Master all 30 flashcards
Learn DSM-5 criteria and assessment methods for cognitive-related disorders, essential for clinical understanding and diagnosis.
Mastering this deck equips you with essential knowledge of diagnostic criteria and assessment tools, enabling accurate identification and differentiation of cognitive disorders in clinical practice. It enhances your ability to interpret assessment results and apply appropriate diagnostic frameworks, improving patient outcomes.
Showing 20 of 30 cardsSample view
| # | Front | Back | Hint |
|---|---|---|---|
| 1 | What is the primary purpose of neuropsychological assessments in cognitive dysfunction? | To evaluate specific cognitive domains such as memory, attention, language, and executive functioning, aiding in diagnosis, treatment planning, and tracking disease progression. | Think of it as a detailed cognitive 'check-up'. |
| 2 | Name two commonly used cognitive screening tools for detecting cognitive impairment. | Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). | Both are brief, standardized tests for quick screening. |
| 3 | According to DSM-5, what is required for a diagnosis of Major Neurocognitive Disorder (Dementia)? | Evidence of significant cognitive decline from previous functioning in one or more cognitive domains, interferes with independence in daily activities, and is not better explained by other mental disorders. | Think 'decline' + 'interference' + 'not due to other causes'. |
| 4 | What is the difference between cognitive screening tests and comprehensive neuropsychological assessments? | Screening tests are brief tools to identify potential impairment, while comprehensive assessments provide detailed evaluation across multiple cognitive domains for diagnosis and treatment planning. | Screening = quick look; Neuropsychology = in-depth analysis. |
| 5 | Which assessment tool is specifically designed to evaluate executive functions? | The Wisconsin Card Sorting Test (WCST) is a widely used measure of executive functioning, including cognitive flexibility, problem-solving, and set-shifting. | Think 'sorting cards' to assess flexibility. |
| 6 | What are the key DSM-5 criteria for diagnosing Major Neurocognitive Disorder due to Alzheimer’s disease? | Evidence of significant cognitive decline in memory and other cognitive domains, insidious onset, gradual decline, and not better explained by other conditions; supportive biomarkers may be present. | Memory decline + gradual onset + biomarkers. |
| 7 | How does the DSM-5 classify Mild Neurocognitive Disorder? | As a level of cognitive decline that is noticeable but does not interfere significantly with independence in daily activities, serving as a potential precursor to major neurocognitive disorder. | Mild but noticeable impairment. |
| 8 | What is the role of the Clock Drawing Test in cognitive assessment? | A quick screening tool to evaluate visuospatial skills, executive functioning, and numerical knowledge, often used to detect cognitive impairment like dementia. | Draw the clock—check for spatial and planning skills. |
| 9 | Name a biomarker that supports the diagnosis of Alzheimer’s disease. | Amyloid-beta and tau protein levels in cerebrospinal fluid (CSF), or amyloid PET imaging, can support the diagnosis by indicating characteristic pathological changes. | Biological clues from spinal fluid or imaging. |
| 10 | What is the significance of the Functional Activities Questionnaire (FAQ)? | It assesses a patient's ability to perform daily activities, helping determine the impact of cognitive impairment on independence. | Functional capacity reflects real-world skills. |
| 11 | Describe the purpose of the Trail Making Test in cognitive assessment. | To evaluate visual attention, task switching, processing speed, and executive functioning by requiring the individual to connect numbered and lettered dots in sequence. | Connecting dots tests mental flexibility. |
| 12 | What distinguishes vascular neurocognitive disorder from Alzheimer’s disease in assessment? | Vascular disorder often presents with a stepwise decline and focal neurological signs, with neuroimaging showing cerebrovascular disease, whereas Alzheimer’s typically shows insidious, progressive decline. | Pattern of decline and imaging clues. |
| 13 | In what ways can neuroimaging assist in diagnosing cognitive disorders? | Neuroimaging (MRI, CT) can identify structural brain changes, vascular lesions, atrophy patterns, or biomarkers supportive of specific neurocognitive disorders. | Brain scans as visual aids. |
| 14 | What is the main limitation of solely relying on clinical interview for diagnosing cognitive disorders? | Subjectivity and potential bias; may miss subtle deficits or differentiate between similar conditions without objective testing. | Clinical interview is vital but not sufficient alone. |
| 15 | Explain the concept of 'cognitive reserve' and its relevance in assessment. | Cognitive reserve refers to the brain's resilience to neuropathology; individuals with higher reserve may show fewer clinical symptoms despite similar levels of brain pathology. | Resilience = brain's buffer. |
| 16 | What is the purpose of using standardized neuropsychological test batteries? | To obtain reliable, valid, and comparable measures of multiple cognitive domains, facilitating diagnosis, monitoring, and research. | Standardized tests ensure consistency. |
| 17 | Which DSM-5 criteria help differentiate between delirium and dementia? | Delirium has an acute onset, fluctuating course, and disturbance in consciousness, whereas dementia develops insidiously with a generally stable level of consciousness. | Onset and consciousness level distinguish them. |
| 18 | How does the Functional Assessment Staging Test (FAST) contribute to diagnosis? | It stages the progression of Alzheimer’s disease based on functional decline, guiding treatment and prognosis. | Staging based on daily function. |
| 19 | What role does the Neuropsychiatric Inventory (NPI) play in cognitive assessments? | It assesses behavioral and psychological symptoms associated with neurocognitive disorders, such as agitation, depression, and psychosis. | Behavioral symptoms complement cognitive testing. |
| 20 | Explain the significance of the DSM-5 specifiers for neurocognitive disorders. | Specifiers (e.g., mild, major, with behavioral disturbance) help tailor diagnosis, prognosis, and treatment planning based on severity and features. | Details refine the diagnosis. |
Note: This preview shows only the first 20 cards. The complete deck contains 30 total cards. Start studying to access all flashcards.
Master all 30 flashcards
Explore other decks you might find helpful